Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Intercept Pharmaceuticals
company
About
Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases.
- 501 - 1000
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $41M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2002
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Intercept Pharmaceuticals is a biopharmaceutical company, that engages in discovering and developing small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. It offers INT-747, an FXR modulating agent that treats patients with chronic autoimmune liver diseases. The company's drug development programs also focus on modulating bile acid receptors, and amelioration of metabolic and hepatic functions in chronic liver diseases
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$41M
Intercept Pharmaceuticals has raised a total of
$41M
in funding over 2 rounds. Their latest funding was raised on
May 16, 2006 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 16, 2006 | Series Unknown | $41M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Intercept Pharmaceuticals is funded by 1 investors.
Jafco Life Science
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
